Tue 2/25/2020 03:34 ET
DJIA27960.80995.403.56%TELCO189.521.840.97%GOLD1648.9527.701.68%Shanghai3013.0518.080.60%
S&P 5003225.90108.073.35%BANKS480.4116.333.40%OIL51.530.100.19%BITCOIN9572.5774.670.78%
NASDAQ9221.28342.113.71%PHARM602.9814.532.41%US/EU1.090.000.00%Futures3247.1220.780.64%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - AEterna Zentaris - AEZS   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add AEZS
  
From: stormcat (Rep: 464)Date: 12/20/2017 17:08
Forum: AEterna Zentaris - Msg #2635Thread #673975506 (Rec: 0)

Aeterna Zentaris Announces FDA Approval of Macrilen ™ (macimorelin) for Diagnosis of Adult Growth Hormone Deficiency
HALTED


2017-12-20 17:00 ET - News Release



CHARLESTON, S.C., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS), a specialty biopharmaceutical company engaged in developing and commercializing pharmaceutical therapies, announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Macrilen™ (macimorelin), an orally available ghrelin agonist, to be used in the diagnosis of patients with adult growth hormone deficiency (AGHD). The Company estimates that approximately 60,000 tests for suspected AGHD are being conducted each year across the United States, Canada and Europe

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser stormcat: Reward | Watch | IgnoreAEZS: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add AEZS
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.